510(k) Report

510(k) · Cleared

Cleared

OxyHeal 4000 Multiplace Hyperbaric Chamber Family

K163109510(k) SpecialCleared Mar 22, 2017135-day reviewClass II21 CFR 868.5470

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Oxyheal Medical Systems, Inc. · CBF Chamber, Hyperbaric

Cleared on Mar 22, 2017 as substantially equivalent to K152223 (Oxyheal Medical Systems, Inc., 2016) after a 135-day review. Its family tree reaches back 4 generations to 1986.

Decided
Mar 22, 2017
Review
135 days
Class
Class II
Product code
CBF
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K862198 (1986). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK862198 Sigma II - Dual Place Hyperbaric ChamberPerry Baromedical Services · 1986
  2. 3 generations backK960389 Hyperbaric ChamberTampa Hyperbaric Ent. · 1996
  3. 2 generations backK011866 Oxyheal 2000 Hyperbaric Chamber Series, Model Oxyheal 2000 SeriesHyperbaric Technologies, Inc. · 2002
  4. 1 generation backK152223 Rectangular Multiplace Hyperbaric Chamber System Product Family with…Oxyheal Medical Systems, Inc. · 2016
  5. This deviceK163109 OxyHeal 4000 Multiplace Hyperbaric Chamber FamilyOxyheal Medical Systems, Inc. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K862198Sigma II - Dual Place Hyperbaric ChamberPerry Baromedical Services1986—
−3K960389Hyperbaric ChamberTampa Hyperbaric Ent.1996—
−2K011866Oxyheal 2000 Hyperbaric Chamber Series, Model Oxyheal 2000 SeriesHyperbaric Technologies, Inc.2002—
−1K152223Rectangular Multiplace Hyperbaric Chamber System Product Family with…Oxyheal Medical Systems, Inc.2016—
0 (this device)K163109OxyHeal 4000 Multiplace Hyperbaric Chamber FamilyOxyheal Medical Systems, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
199520
200310
FIG. 1 — Lineage of K163109, 1986–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CBF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CBF device

  1. #1 K240569 FESL FINK Chamber; FEDL FINK Chamber; FETL…score 8.7 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K152223Rectangular Multiplace Hyperbaric Chamber System Product Family with Touchscreen Control…
Summary page 4
…: II FDA Establishment Registration #: 1000519737 5. Predicate Device OxyHeal® 5000 Rectangular Multiplace Hyperbaric Chamber System Product Family (K152223) 6. Device Description The OxyHeal® 4000 Cylindrical Multiplace Hyperbaric Chamber System Product Family is comprised of a multi…
Oxyheal Medical Systems, Inc.2016—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 4 companies; a new generation was cleared every 10.1 years on median.
  • None of the 8 ancestors has a recall.

How does its category compare?

All CBF devices

CBF Chamber, Hyperbaric: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · CBF

1in 2024

2008: 32009: 12010: 32011: 12014: 12016: 12017: 12019: 12023: 12024: 1
2007high 3 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CBF

87in 2010

2008: 134 days median2010: 87 days median
2007high 134 (2008) · low 87 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CBF

2in 2008

2008: 2
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CBF

25in 2025

2007: 22009: 12010: 112011: 52012: 92013: 12014: 52015: 32016: 52017: 92018: 52019: 32020: 42021: 62022: 92023: 132024: 132025: 25
2007high 25 (2025) · low 0 (2008)2025

MAUDE reports naming product code CBF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
2008313420
20091—01
2010387011
20111—05
20120—09
20130—01
20141—05
20150—03
20161—05
20171—09
20180—05
20191—03
20200—04
20210—06
20220—09
20231—013
20241—013
20250—025
20260—0—

What is it indicated for?

The following indications which are listed on the Undersea & Hyperbaric Medical Society (UHMS) web site: www.uhms.org are approved uses of hyperbaric oxygen therapy as defined by the Hyperbaric Oxygen Therapy Committee. . Air or Gas Embolism . Carbon Monoxide Poisoning . Carbon Monoxide Poisoning Complicated by Cyanide Poisoning . Clostridial Myositis and Myonecrosis (Gas Gangrene) . Crush Injury, Compartment Syndrome and Other Acute Ischemias .…

Read the full statement (117 words)

The following indications which are listed on the Undersea & Hyperbaric Medical Society (UHMS) web site: www.uhms.org are approved uses of hyperbaric oxygen therapy as defined by the Hyperbaric Oxygen Therapy Committee.

. Air or Gas Embolism

. Carbon Monoxide Poisoning

. Carbon Monoxide Poisoning Complicated by Cyanide Poisoning

. Clostridial Myositis and Myonecrosis (Gas Gangrene)

. Crush Injury, Compartment Syndrome and Other Acute Ischemias

. Decompression Sickness

. Arterial Insufficiencies

. Central Retinal Artery Occlusion

. Enhancement of Healing in Selected Problem Wounds

. Severe Anemia

. Intracranial Abscess

9. Necrotizing Soft Tissue Infections

10. Osteomyelitis (Refractory)

11. Delayed Radiation Injury (Soft Tissue and Bony Necrosis)

12. Compromised Grafts and Flaps

13. Acute Thermal Burn Injury

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K163109: OxyHeal 4000 Multiplace Hyperbaric Chamber Family.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K163109

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026